G6PD and G6PD deficiency: In conclusion, our haematological and clinical data provide evidence of the safety of single low dose of primaquine in populations with a high prevalence of G6PD deficiency and so support a broader use of low dose primaquine without G6PD testing for the treatment and elimination of falciparum malaria.